School of Pharmacy, Sungkyunkwan University, Suwon, Republic of Korea
In Vivo. 2021 Nov-Dec;35(6):3039-3044. doi: 10.21873/invivo.12599.
Certain diseases and age groups are associated with a higher incidence of cancer. Cancer prevention can be achieved using repositioned drugs that have anticancer ability, thereby reducing the incidence of cancer in susceptible individuals. This implies that the selection of repositioned drugs can have dual benefits: controlling pre-existing diseases and facilitating cancer prevention. This report outlines the rationale underlying drug repositioning for medications with an anticancer effect and discusses its advantages. We discuss repositioned drugs with anticancer effects that may contribute to cancer prevention in susceptible individuals and the general population with temporary, treatable conditions. The discussion of drug repositioning in this review should facilitate the initiation of clinical trials and lead to therapeutic application of such drugs to reduce the incidence of cancer in susceptible individuals.
某些疾病和年龄组与更高的癌症发病率相关。可以使用具有抗癌能力的重新定位药物来预防癌症，从而降低易感个体的癌症发病率。这意味着选择重新定位的药物可以带来双重好处：控制现有疾病和促进癌症预防。本报告概述了具有抗癌作用的药物重新定位的基本原理，并讨论了其优势。我们讨论了具有抗癌作用的重新定位药物，这些药物可能有助于预防易感个体和患有暂时性、可治疗疾病的一般人群的癌症。本综述中对药物重新定位的讨论应有助于启动临床试验，并导致此类药物的治疗应用，以降低易感个体的癌症发病率。
